Global Spinal Cord Stimulators market size earned around $2880 Billion in 2019 and is expected to reach $4120 Billion by 2026, with a projected CAGR of 8%.
The Spinal Cord Stimulators Market is set for quick growth over the forecast period. In terms of revenue, the global Spinal Cord Stimulators Market was valued at USD 2880 billion in 2019. It is expected that the market will be valued at USD 4120 billion by 2026 rising at a CAGR of 8.0%.
A Spinal Cord Stimulator (SCS) device is surgically placed under the skin and sends a mild electric current to the spinal cord. It helps in the reduction of pain because the electrical pulses modify and mask the pain signal from reaching the brain.
The rising population suffering from chronic pain, favorable reimbursement policies, and a rise in the adoption of spinal cord stimulators for the relief of pain are some of the key aspects that are boosting the growth of the global spinal cord stimulator market.
Emerging spinal cord stimulation therapy guidelines is also driving the growth of the global spinal cord stimulators market. Covid-19 impacted negatively the healthcare industry resulting in the decline of spinal cord stimulation.
However, an increase in well-established healthcare sectors and the rising awareness among patients of advanced technology for pain management are driving the growth of the market. Ongoing research and investment by the government are also contributing to the growth of the spinal cord stimulators market globally.
The Spinal Cord Stimulators Market is segmented based on disease indication, product, end-user, and region. On the basis of disease indication, the Spinal Cord Stimulators Market is segmented into complex regional pain syndrome (CRPS), failed back surgery syndrome (FBSS), degenerative disc disease, and others. Based on the product, the Spinal Cord Stimulators Market is bifurcated into non-rechargeable and rechargeable. On the basis of end-user, the Spinal Cord Stimulators Market is bifurcated into ambulatory surgical centers, hospitals, and specialty clinics.
North America is expected to contribute to the maximum share in the global spinal cord stimulators market over the forecast period due to factors such as emerging guidelines by the government, favorable health reimbursements, and the adoption of advanced technologies.
The Asia Pacific is forecasted to be the fastest growing region owing to the rise in the number of patients and the rise in preference of the patients for advanced technologies & noninvasive methods for the treatment of neuropathic pain.
Report Attributes | Report Details |
---|---|
Report Name | Spinal Cord Stimulators Market |
Market Size in 2019 | USD 2880 billion |
Market Forecast in 2026 | USD 4120 billion |
Compound Annual Growth Rate | CAGR of 8.0% |
Number of Pages | 110 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | Boston Scientific Corporation, Medtronic, Abbott, Nevro Corporation, Saluda Medical Pvt Ltd, Nuvectra Corporation, Neuros Medical, Stimwave LLC, NeuroSigma, Synapse Biomedical Inc., and Cook Medical. The key players are forming various strategies such as product launches, collaborations, product development |
Segments Covered | By Disease Indication, By Product, By End User And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latian America, Middle East and Africa (MEA) |
Countries Covered | North America: U.S and Canada Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific Latin America: Brazil, Argentina, Chile The Middle East And Africa: South Africa, GCC, Rest of MEA |
Base Year | 2019 |
Historical Year | 2015 to 2019 |
Forecast Year | 2020 - 2026 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Some of the key players in the Spinal Cord Stimulators Market are Boston Scientific Corporation, Medtronic, Abbott, Nevro Corporation, Saluda Medical Pvt Ltd, Nuvectra Corporation, Neuros Medical, Stimwave LLC, NeuroSigma, Synapse Biomedical Inc., and Cook Medical. The key players are forming various strategies such as product launches, collaborations, product development, and partnerships to gain a competitive advantage in the market.
FrequentlyAsked Questions
The Global Spinal Cord Stimulators Market was valued at USD 2880 million in 2019.
The Global Spinal Cord Stimulators Market is expected to reach USD 4120 million by 2026.
Some of the key factors driving the Global Spinal Cord Stimulators Market growth are rising population suffering from chronic pain, favorable reimbursement policies, and a rise in the adoption of spinal cord stimulators for the relief of pain.
North America is expected to contribute to the maximum share in the global spinal cord stimulators market over the forecast period due to factors such as the emerging guidelines by the government, favorable health reimbursements, adoption of advanced technologies.
Some of the major companies operating in the Global Spinal Cord Stimulators Market are Boston Scientific Corporation, Medtronic, Abbott, Nevro Corporation, Saluda Medical Pvt Ltd, Nuvectra Corporation, Neuros Medical, Stimwave LLC, NeuroSigma, Synapse Biomedical Inc., Cook Medical.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed